Patricia Richter
Dados Biográficos
| ID | 6684380 |
|---|---|
| NOME | Patricia Richter |
| PRENOMES | Patricia |
| SOBRENOME | Richter |
| ASSINATURA | RICHTER P |
| AFILIAÇÕES | Centers for Disease Control and Prevention |
| ORCID | 0000-0003-2370-314X |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 15 |
| TOTAL DE CITAÇÕES | 2 |
| TOTAL COMO AUTOR | 15 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2004 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 1 |
Implementation of the Noncommunicable Disease Capacity Assessment and Planning Process in Iraq, Jordan, and Pakistan
The N-CAP Process effectively creates structured, multisectoral recommendations and actionable plans to increase national capacity to address public health threats, such as NCDs. By facilitating comprehensive assessments and fostering governmental and multisectoral engagement, the N-CAP Process serves as an adaptable resource for countries and other regions grappling with similar public health challenges
Addressing emerging public health threats
Background: The global epidemic of noncommunicable diseases (NCDs) is increasing. Current assessments that monitor capacity to address NCDs are often externally led and do not facilitate country planning. The Noncommunicable Disease Capacity Assessment and Planning (N-CAP) Process assists ministries of health and other governmental and non-governmental stakeholders to assess, prioritize, and plan how to address NCDs and other public health threat…
Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries
Despite the high burden of hyperlipidemia and the effectiveness of treatment, evidence suggests that the accessibility of hyperlipidemia medicines can be low in many low- and middle-income countries (LMICs). The aim of this study was to identify common barriers to the accessibility of medicines for hyperlipidemia in LMICs. A multimethod analysis and multiple data sources were used to assess the accessibility and barriers of medicines for hyperlip…
The HEARTS partner forum—supporting implementation of HEARTS to treat and control hypertension
Cardiovascular diseases (CVD), principally ischemic heart disease (IHD) and stroke, are the leading causes of death (18. 6 million deaths annually) and disability (393 million disability-adjusted life-years lost annually), worldwide. High blood pressure is the most important preventable risk factor for CVD and deaths, worldwide (10.8 million deaths annually). In 2016, the World Health Organization (WHO) and the United States Centers for Disease C…
Associations of diabetes, hypertension and obesity with Covid-19 mortality
Noncommunicable disease outcomes and the effects of vertical and horizontal health aid
Foreign health aid forms a substantial portion of health spending in many low- and middle-income countries (LMICs). It can be either vertical (funds earmarked for specific diseases) or horizontal (funds used for broad health sector strengthening). Historically, most health aid has been disbursed vertically toward key infectious diseases, with minimal allocations to noncommunicable diseases (NCDs). High NCD burden in LMICs underscores a need for i…
Revisiting the association between worldwide implementation of the MPOWER package and smoking prevalence, 2008–2017
A decade after the introduction of the WHO MPOWER package, we observed that the countries with higher initial tobacco control preparedness and higher smoking burden were able to reduce the adult daily smoking prevalence significantly
Smoking Behavior and Exposure
Our results suggest that mentholation has an effect on measures of smoking behavior and that mouth level nicotine is a useful indicator of between-brand smoke exposure
Global surveillance of oral tobacco products
These data have important implications for risk assessment because they show that very different exposure risks may be posed through the use of these chemically diverse oral tobacco products. Because of the wide chemical variation, oral tobacco products should not be categorised together when considering the public health implications of their use
Tobacco Smoke Exposure and Levels of Urinary Metals in the U.S. Youth and Adult Population
We assessed 12 urine metals in tobacco smoke-exposed and not exposed National Health and Nutrition Examination Survey participants. Our analysis included age, race/ethnicity, and poverty status. Gender and racial/ethnic differences in cadmium and lead and creatinine-adjusted and unadjusted data for group comparisons are presented. Smokers' had higher cadmium, lead, antimony, and barium levels than nonsmokers. Highest lead levels were in the young…
Small-group discussions on menthol cigarettes
Some topics suggested by the participants warrant further investigation. More research is needed to assess the pervasiveness of these beliefs and their potential utility for smoking cessation interventions
What Do Adult Smokers Think About Ads and Promotional Materials for PREPs
Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco
The risks of dying from major tobacco-related diseases were higher among former cigarette smokers who switched to spit tobacco after they stopped smoking than among those who quit using tobacco entirely
Young Adult Smoker Risk Perceptions of Traditional Cigarettes and Nontraditional Tobacco Products
Determination of tar, nicotine, and carbon monoxide yields in the mainstream smoke of selected international cigarettes
Analysis of the smoke deliveries suggested that cigarettes from the Eastern Mediterranean, Southeast Asia, and Western Pacific WHO regions tended to have higher tar, nicotine, and CO smoke deliveries than did brands from the European, American, or African WHO regions surveyed
Small-group discussions on menthol cigarettes
Some topics suggested by the participants warrant further investigation. More research is needed to assess the pervasiveness of these beliefs and their potential utility for smoking cessation interventions
Determination of tar, nicotine, and carbon monoxide yields in the mainstream smoke of selected international cigarettes
Analysis of the smoke deliveries suggested that cigarettes from the Eastern Mediterranean, Southeast Asia, and Western Pacific WHO regions tended to have higher tar, nicotine, and CO smoke deliveries than did brands from the European, American, or African WHO regions surveyed
Young Adult Smoker Risk Perceptions of Traditional Cigarettes and Nontraditional Tobacco Products
What Do Adult Smokers Think About Ads and Promotional Materials for PREPs
Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco
The risks of dying from major tobacco-related diseases were higher among former cigarette smokers who switched to spit tobacco after they stopped smoking than among those who quit using tobacco entirely
Small-group discussions on menthol cigarettes
Some topics suggested by the participants warrant further investigation. More research is needed to assess the pervasiveness of these beliefs and their potential utility for smoking cessation interventions
Tobacco Smoke Exposure and Levels of Urinary Metals in the U.S. Youth and Adult Population
We assessed 12 urine metals in tobacco smoke-exposed and not exposed National Health and Nutrition Examination Survey participants. Our analysis included age, race/ethnicity, and poverty status. Gender and racial/ethnic differences in cadmium and lead and creatinine-adjusted and unadjusted data for group comparisons are presented. Smokers' had higher cadmium, lead, antimony, and barium levels than nonsmokers. Highest lead levels were in the young…
Global surveillance of oral tobacco products
These data have important implications for risk assessment because they show that very different exposure risks may be posed through the use of these chemically diverse oral tobacco products. Because of the wide chemical variation, oral tobacco products should not be categorised together when considering the public health implications of their use
Smoking Behavior and Exposure
Our results suggest that mentholation has an effect on measures of smoking behavior and that mouth level nicotine is a useful indicator of between-brand smoke exposure
Noncommunicable disease outcomes and the effects of vertical and horizontal health aid
Foreign health aid forms a substantial portion of health spending in many low- and middle-income countries (LMICs). It can be either vertical (funds earmarked for specific diseases) or horizontal (funds used for broad health sector strengthening). Historically, most health aid has been disbursed vertically toward key infectious diseases, with minimal allocations to noncommunicable diseases (NCDs). High NCD burden in LMICs underscores a need for i…
Revisiting the association between worldwide implementation of the MPOWER package and smoking prevalence, 2008–2017
A decade after the introduction of the WHO MPOWER package, we observed that the countries with higher initial tobacco control preparedness and higher smoking burden were able to reduce the adult daily smoking prevalence significantly
The HEARTS partner forum—supporting implementation of HEARTS to treat and control hypertension
Cardiovascular diseases (CVD), principally ischemic heart disease (IHD) and stroke, are the leading causes of death (18. 6 million deaths annually) and disability (393 million disability-adjusted life-years lost annually), worldwide. High blood pressure is the most important preventable risk factor for CVD and deaths, worldwide (10.8 million deaths annually). In 2016, the World Health Organization (WHO) and the United States Centers for Disease C…
Associations of diabetes, hypertension and obesity with Covid-19 mortality
Addressing emerging public health threats
Background: The global epidemic of noncommunicable diseases (NCDs) is increasing. Current assessments that monitor capacity to address NCDs are often externally led and do not facilitate country planning. The Noncommunicable Disease Capacity Assessment and Planning (N-CAP) Process assists ministries of health and other governmental and non-governmental stakeholders to assess, prioritize, and plan how to address NCDs and other public health threat…
Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries
Despite the high burden of hyperlipidemia and the effectiveness of treatment, evidence suggests that the accessibility of hyperlipidemia medicines can be low in many low- and middle-income countries (LMICs). The aim of this study was to identify common barriers to the accessibility of medicines for hyperlipidemia in LMICs. A multimethod analysis and multiple data sources were used to assess the accessibility and barriers of medicines for hyperlip…
Implementation of the Noncommunicable Disease Capacity Assessment and Planning Process in Iraq, Jordan, and Pakistan
The N-CAP Process effectively creates structured, multisectoral recommendations and actionable plans to increase national capacity to address public health threats, such as NCDs. By facilitating comprehensive assessments and fostering governmental and multisectoral engagement, the N-CAP Process serves as an adaptable resource for countries and other regions grappling with similar public health challenges
Medicine (13 obras) · Environmental health (9 obras) · Internal Medicine (7 obras) · Smoking Behavior and Cessation (7 obras) · Business (6 obras) · Global Public Health Policies and Epidemiology (6 obras) · Public health (6 obras) · Population (5 obras) · Chemistry (4 obras) · Nicotine (4 obras)